Reducing the level of undecaprenyl pyrophosphate synthase has complex effects on susceptibility to cell wall antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4267-4275

  Lee, Yong Heon ^a   Helmann, John D ^a  

^a Department of Molecular Biology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; FARNESYL TRANS TRANSFERASE; FOSFOMYCIN; VANCOMYCIN;

3' UNTRANSLATED REGION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BINDING SITE; CELL WALL; CONTROLLED STUDY; DNA SEQUENCE; ENZYME SYNTHESIS; GENE FREQUENCY; POINT MUTATION; PRIORITY JOURNAL; RIBOSOME; RNA TRANSLATION;

EID: 84882321076     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00794-13     Document Type: Article

References (60)

1. Fischbach MA, Walsh CT. 2009. Antibiotics for emerging pathogens. Science 325:1089-1093.
2. Chambers HF, Deleo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641.
3. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6:29-40.
4. Sinko W, de Oliveira C, Williams S, Van Wynsberghe A, Durrant JD, Cao R, Oldfield E, McCammon JA. 2011. Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target. Chem. Biol. Drug Design 77:412-420.
5. Ogura K, Koyama T. 1998. Enzymatic aspects of isoprenoid chain elongation. Chem. Rev. 98:1263-1276.
6. Takahashi I, Ogura K. 1982. Prenyltransferases of Bacillus subtilis: undecaprenyl pyrophosphate synthetase and geranylgeranyl pyrophosphate synthetase. J. Biochem. 92:1527-1537.
7. Teng KH, Liang PH. 2012. Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis. Bioorg. Chem. 43:51-57.
8. Li H, Huang J, Jiang X, Seefeld M, McQueney M, Macarron R. 2003. The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors. J. Biomol. Screening 8:712-715.
9. Guo RT, Cao R, Liang PH, Ko TP, Chang TH, Hudock MP, Jeng WY, Chen CK, Zhang Y, Song Y, Kuo CJ, Yin F, Oldfield E, Wang AH. 2007. Bisphosphonates target multiple sites in both cis-and transprenyltransferases. Proc. Natl. Acad. Sci. U. S. A. 104:10022-10027.
10. Peukert S, Sun Y, Zhang R, Hurley B, Sabio M, Shen X, Gray C, Dzink-Fox J, Tao J, Cebula R, Wattanasin S. 2008. Design and structureactivity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids, and dihydropyridin-2-ones. Bioorg. Med. Chem. Lett. 18:1840-1844.
11. Kuo CJ, Guo RT, Lu IL, Liu HG, Wu SY, Ko TP, Wang AH, Liang PH. 2008. Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases. J. Biomed. Biotechnol. 2008:841312. doi:10.1155/2008/841312.
12. Inokoshi J, Nakamura Y, Hongbin Z, Uchida R, Nonaka K, Masuma R, Tomoda H. 2013. Spirohexalines, new inhibitors of bacterial undecaprenyl pyrophosphate synthase, produced by Penicillium brasilianum FKI-3368. J. Antibiot. 66:37-41.
13. Nieto M, Perkins HR. 1971. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex formation with vancomycin. Biochem. J. 123: 789-803.
14. Reynolds PE. 1989. Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
15. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (ed).1995. Manual of clinical microbiology, 6th ed. ASM Press, Washington, DC.
16. Walsh C. 1999. Deconstructing vancomycin. Science 284:442-443.
17. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
18. Gould IM. 2010. VRSA-doomsday superbug or damp squib? Lancet Infect. Dis. 10:816-818.
19. Courvalin P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42(Suppl 1):S25-S34.
20. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.
21. Noble WC, Virani Z, Cree RG. 1992. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:195-198.
22. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. 2007. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20:79-114.
23. Pootoolal J, Neu J, Wright GD. 2002. Glycopeptide antibiotic resistance. Annu. Rev. Pharmacol. Toxicol. 42:381-408.
24. Arthur M, Molinas C, Courvalin P. 1992. The VanS-VanR twocomponent regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174: 2582-2591.
25. Lebreton F, Depardieu F, Bourdon N, Fines-Guyon M, Berger P, Camiade S, Leclercq R, Courvalin P, Cattoir V. 2011. D-Ala-D-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 55:4606-4612.
26. Boyd DA, Willey BM, Fawcett D, Gillani N, Mulvey MR. 2008. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob. Agents Chemother. 52:2667-2672.
27. Xu X, Lin D, Yan G, Ye X, Wu S, Guo Y, Zhu D, Hu F, Zhang Y, Wang F, Jacoby GA, Wang M. 2010. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob. Agents Chemother. 54:4643-4647.
28. Jansen A, Turck M, Szekat C, Nagel M, Clever I, Bierbaum G. 2007. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. Int. J. Med. Microbiol. 297:205-215.
29. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, Tomasz A. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 104:9451-9456.
30. Howden BP, Stinear TP, Allen DL, Johnson PD, Ward PB, Davies JK. 2008. Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob. Agents Chemother. 52:3755-3762.
31. Kato Y, Suzuki T, Ida T, Maebashi K. 2010. Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. J. Antimicrob. Chemother. 65: 37-45.
32. Kervick GN, Flynn HW, Jr, Alfonso E, Miller D. 1990. Antibiotic therapy for Bacillus species infections. Am. J. Ophthalmol. 110:683-687.
33. Cao M, Wang T, Ye R, Helmann JD. 2002. Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilis -W and m regulons. Mol. Microbiol. 45:1267-1276.
34. Harwood CR, Cutting SM. 1990. Molecular biological methods for Bacillus. Wiley, New York, NY.
35. Bordi C, Butcher BG, Shi Q, Hachmann AB, Peters JE, Helmann JD. 2008. In vitro mutagenesis of Bacillus subtilis by using a modified Tn7 transposon with an outward-facing inducible promoter. Appl. Environ. Microbiol. 74:3419-3425.
36. Salipante SJ, Barlow M, Hall BG. 2003. GeneHunter, a transposon tool for identification and isolation of cryptic antibiotic resistance genes. Antimicrob. Agents Chemother. 47:3840-3845.
37. Peters JE, Craig NL. 2000. Tn7 transposes proximal to DNA doublestrand breaks and into regions where chromosomal DNA replication terminates. Mol. Cell 6:573-582.
38. Srivatsan A, Han Y, Peng J, Tehranchi AK, Gibbs R, Wang JD, Chen R. 2008. High-precision, whole-genome sequencing of laboratory strains facilitates genetic studies. PLoS Genet. 4:e1000139. doi:10.1371/journal .pgen.1000139.
39. Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD. 2003. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon. Mol. Microbiol. 50:1591-1604.
40. Wach A. 1996. PCR-synthesis of marker cassettes with long flanking homology regions for gene disruptions in Saccharomyces cerevisiae. Yeast 12:259-265.
41. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Quisel JD, Burkholder WF, Grossman AD. 2001. In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis. J. Bacteriol. 183:6573-6578.
43. Lee YH, Nam KH, Helmann JD. 2013. A mutation of the RNA polymerase beta' subunit (rpoC) confers cephalosporin resistance in Bacillus subtilis. Antimicrob. Agents Chemother. 57:56-65.
44. Smaldone GT, Antelmann H, Gaballa A, Helmann JD. 2012. The FsrA sRNA and FbpB protein mediate the iron-dependent induction of the Bacillus subtilis lutABC iron-sulfur-containing oxidases. J. Bacteriol. 194: 2586-2593.
45. Hachmann AB, Angert ER, Helmann JD. 2009. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob. Agents Chemother. 53:1598-1609.
46. Inaoka T, Ochi K. 2012. Undecaprenyl pyrophosphate involvement in susceptibility of Bacillus subtilis to rare earth elements. J. Bacteriol. 194: 5632-5637.
47. Price MN, Huang KH, Alm EJ, Arkin AP. 2005. A novel method for accurate operon predictions in all sequenced prokaryotes. Nucleic Acids Res. 33:880-892.
48. Luo Y, Helmann JD. 2012. Analysis of the role of Bacillus subtilis sigma( M) in beta-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol. Microbiol. 83:623-639.
49. Eiamphungporn W, Helmann JD. 2008. The Bacillus subtilis m regulon and its contribution to cell envelope stress responses. Mol. Microbiol. 67:830-848.
50. Mascher T, Hachmann AB, Helmann JD. 2007. Regulatory overlap and functional redundancy among Bacillus subtilis extracytoplasmic function sigma factors. J. Bacteriol. 189:6919-6927.
51. Thackray PD, Moir A. 2003. SigM, an extracytoplasmic function sigma factor of Bacillus subtilis, is activated in response to cell wall antibiotics, ethanol, heat, acid, and superoxide stress. J. Bacteriol. 185:3491-3498.
52. D'Elia MA, Millar KE, Bhavsar AP, Tomljenovic AM, Hutter B, Schaab C, Moreno-Hagelsieb G, Brown ED. 2009. Probing teichoic acid genetics with bioactive molecules reveals new interactions among diverse processes in bacterial cell wall biogenesis. Chem. Biol. 16:548-556.
53. Magnusson LU, Farewell A, Nystrom T. 2005. ppGpp: a global regulator in Escherichia coli. Trends Microbiol. 13:236-242.
54. Artsimovitch I, Patlan V, Sekine S, Vassylyeva MN, Hosaka T, Ochi K, Yokoyama S, Vassylyev DG. 2004. Structural basis for transcription regulation by alarmone ppGpp. Cell 117:299-310.
55. Cao M, Bernat BA, Wang Z, Armstrong RN, Helmann JD. 2001. FosB, a cysteine-dependent fosfomycin resistance protein under the control of -W, an extracytoplasmic-function sigma factor in Bacillus subtilis. J. Bacteriol. 183:2380-2383.
56. Cao M, Helmann JD. 2002. Regulation of the Bacillus subtilis bcrC bacitracin resistance gene by two extracytoplasmic function sigma factors. J. Bacteriol. 184:6123-6129.
57. Endo S, Zhang YW, Takahashi S, Koyama T. 2003. Identification of human dehydrodolichyl diphosphate synthase gene. Biochim. Biophys. Acta 1625:291-295.
58. Zuchner S, Dallman J, Wen R, Beecham G, Naj A, Farooq A, Kohli MA, Whitehead PL, Hulme W, Konidari I, Edwards YJ, Cai G, Peter I, Seo D, Buxbaum JD, Haines JL, Blanton S, Young J, Alfonso E, Vance JM, Lam BL, Pericak-Vance MA. 2011. Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa. Am. J. Hum. Genet. 88:201-206.
59. Zelinger L, Banin E, Obolensky A, Mizrahi-Meissonnier L, Beryozkin A, Bandah-Rozenfeld D, Frenkel S, Ben-Yosef T, Merin S, Schwartz SB, Cideciyan AV, Jacobson SG, Sharon D. 2011. A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews. Am. J. Hum. Genet. 88:207-215.
60. Lee YH, Kingston AW, Helmann JD. 2012. Glutamate dehydrogenase affects resistance to cell wall antibiotics in Bacillus subtilis. J. Bacteriol. 194:993-1001.